These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9717036)

  • 61. Effect of hepatocyte growth-promoting factors on myocardial ischemia during exercise in patients with severe coronary artery disease.
    Wang N; Tong G; Yang J; Zhou Z; Pan H; Huo Y; Xu J; Zhang X; Ling F; Li P
    Int Heart J; 2009 May; 50(3):291-9. PubMed ID: 19506333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X.
    Rosano GM; Peters NS; Lefroy D; Lindsay DC; Sarrel PM; Collins P; Poole-Wilson PA
    J Am Coll Cardiol; 1996 Nov; 28(6):1500-5. PubMed ID: 8917264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute effects of transdermal estrogen in postmenopausal women with coronary artery disease. Using a clinically relevant estrogen dose and concurrent antianginal therapy.
    Manhem K; Ahlm H; Dellborg M; Milsom I
    Cardiology; 2000; 94(2):86-90. PubMed ID: 11173778
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diltiazem alone and combined with nitroglycerin: effect on normal and diseased human coronary arteries.
    Hess OM; Nonogi H; Bortone A; Gage JE; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Nov; 10 Suppl F():142-6. PubMed ID: 2515968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P
    Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The acute effects of sublingual 17beta-estradiol on the cardiovascular system.
    Pines A; Averbuch M; Fisman EZ; Rosano GM
    Maturitas; 1999 Sep; 33(1):81-5. PubMed ID: 10585176
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute anti-ischemic effect of testosterone in men with coronary artery disease.
    Rosano GM; Leonardo F; Pagnotta P; Pelliccia F; Panina G; Cerquetani E; della Monica PL; Bonfigli B; Volpe M; Chierchia SL
    Circulation; 1999 Apr; 99(13):1666-70. PubMed ID: 10190874
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon.
    Barbour MM; Garber CE; Ahlberg AW; Cloutier DJ; McClellan JR; Heller GV
    J Am Coll Cardiol; 1993 Oct; 22(4):1155-8. PubMed ID: 7691911
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease.
    Rosano GM; Caixeta AM; Chierchia S; Arie S; Lopez-Hidalgo M; Pereira WI; Leonardo F; Webb CM; Pileggi F; Collins P
    Circulation; 1997 Nov; 96(9):2837-41. PubMed ID: 9386146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Merz CN; Olson MB; McClure C; Yang YC; Symons J; Sopko G; Kelsey SF; Handberg E; Johnson BD; Cooper-DeHoff RM; Sharaf B; Rogers WJ; Pepine CJ
    Am Heart J; 2010 Jun; 159(6):987.e1-7. PubMed ID: 20569710
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of effect of estrogen on rest and treadmill exercise in postmenopausal women without known cardiac disease.
    Lee M; Giardina EG; Homma S; DiTullio MR; Sciacca RR
    Am J Cardiol; 1997 Sep; 80(6):793-7. PubMed ID: 9315595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vascular responses to 17 beta-oestradiol in postmenopausal women.
    Riedel M; Oeltermann A; Mügge A; Creutzig A; Rafflenbeul W; Lichtlen P
    Eur J Clin Invest; 1995 Jan; 25(1):44-7. PubMed ID: 7705386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease.
    Nielsen NE; Ahlner J; Malmstedt J; Ohman KP; Swahn E
    Scand J Clin Lab Invest; 1999 Aug; 59(5):325-34. PubMed ID: 10533844
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estrogen acutely increases peripheral blood flow in postmenopausal women.
    Volterrani M; Rosano G; Coats A; Beale C; Collins P
    Am J Med; 1995 Aug; 99(2):119-22. PubMed ID: 7625415
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.
    Jackson S; Shepherd A; Brookes S; Abrams P
    Br J Obstet Gynaecol; 1999 Jul; 106(7):711-8. PubMed ID: 10428529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularization.
    Ferri C; De Marzio P; Desideri G; Baldoncini R; Bellini C; Morelli S; Santucci A
    Eur J Clin Invest; 1997 Jun; 27(6):526-32. PubMed ID: 9229234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Are the acute effects of transdermal estradiol in postmenopausal women with coronary disease related to changes of the autonomic tone?].
    Schuchert A; Liebau M; Behrens G; Mueck AO; Meinertz T
    Z Kardiol; 2002 Feb; 91(2):156-60. PubMed ID: 11963733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement.
    Cagnacci A; Zanni AL; Veneri MG; Menozzi R; Volpe A; Rio GD
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):367-72. PubMed ID: 10971455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy.
    Buckler HM; Kalsi PK; Cantrill JA; Anderson DC
    Clin Endocrinol (Oxf); 1995 May; 42(5):445-50. PubMed ID: 7621560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
    Owen EJ; Siddle NC; McGarrigle HT; Pugh MA
    Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.